Instil Bio, Inc.
Instil Bio, Inc. scores highest on Price (47) and lowest on Earnings (10). Its PosiPenta is 31.50 out of 100, weaker than most similar companies.
On the Penta Grid this week, Instil Bio, Inc. is Grid #733 of 837 in the Healthcare sector in United States, and Grid #3,527 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Instil Bio, Inc. | 31.50 | 47 | 10 | 23 | 42 | 35 |
| Aldeyra Therapeutics, Inc. | 41.74 | 38 | 53 | 14 | 64 | 39 |
| Veru Inc. | 35.36 | 34 | 35 | 28 | 46 | 33 |
| Nephros, Inc. | 56.23 | 47 | 63 | 56 | 71 | 44 |
| Elutia Inc. | 40.08 | 26 | 34 | 59 | 38 | 44 |
| Dogwood Therapeutics, Inc. | 52.52 | 91 | 44 | 15 | 66 | 47 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -1.33 |
| P/B ratio | 0.37 |
EEarnings
| Trailing EPS | ₹-419.59 |
| Forward EPS | ₹-1386.63 |
NNitro
| Price | 559.77 |
| 52-week high | 1925.27 |
| 52-week low | 537.03 |
| Fall from 52-week high | 70.9% |
TTorque
| Return on equity (ROE) | -25.33% |
| Debt-to-equity | 0.81 |
AAnchor
| Beta (price swings) | 1.94 |
| Market cap | ₹379 Cr |
| Insider holding | 6.56% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Instil Bio, Inc.'s PosiPenta score?
Instil Bio, Inc.'s PosiPenta is 31.50 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Instil Bio, Inc. stand on the Penta Grid?
On the Penta Grid this week, Instil Bio, Inc. is Grid #733 of 837 in the Healthcare sector in United States, and Grid #3,527 of 4,000 in United States.
Which PosiPenta pillar is strongest for Instil Bio, Inc.?
Price (valuation), with a score of 47 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Instil Bio, Inc.?
Earnings (growth), with a score of 10 out of 100: much weaker than most similar companies.
Has Instil Bio, Inc.'s PosiPenta changed since last week?
Yes, it rose 4.01 points, from 27.49 to 31.50.
PositoAI is for research and education only and is not investment advice.